InspireMD, Inc. (NSPR) stock
NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3054% below fair value
$0.65+0.05 (+8.33%)
Close on Nov 17, 2026Market cap $30.22MP/E –Yield –
InspireMD operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
InspireMD's operating cash flow for the twelve months ending Jun 30, 2026 was -$41.21M. For fiscal 2025 it was -$35.10M. The highest annual figure on record is -$1.55M in fiscal 2009.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$35.10M | – |
| FY2024 | Dec 31, 2024 | -$21.87M | – |
| FY2023 | Dec 31, 2023 | -$16.38M | – |
| FY2022 | Dec 31, 2022 | -$15.54M | – |
| FY2021 | Dec 31, 2021 | -$13.21M | – |
| FY2020 | Dec 31, 2020 | -$9.08M | – |
| FY2019 | Dec 31, 2019 | -$9.81M | – |
| FY2018 | Dec 31, 2018 | -$7.61M | – |
| FY2017 | Dec 31, 2017 | -$8.13M | – |
| FY2016 | Dec 31, 2016 | -$7.50M | – |
| FY2015 | Dec 31, 2015 | -$11.60M | – |
| FY2013 | Jun 30, 2013 | -$10.30M | – |
| FY2010 | Dec 31, 2010 | -$2.71M | – |
| FY2009 | Dec 31, 2009 | -$1.55M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$10.90M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.34M | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.35M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.63M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.33M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.79M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.75M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.70M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.35M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.06M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.18M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.04M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.33M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.83M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.20M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.10M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.11M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.13M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.90M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.14M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.53M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.64M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.20M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.04M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.48M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.35M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.57M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.86M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.90M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.49M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.80M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.83M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.19M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.78M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.78M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.01M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.59M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.76M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.88M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.96M | – |
See a number that looks wrong?